| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 831 | 2014 |
| Lentiviral vectors in gene therapy: their current status and future potential D Escors, K Breckpot Archivum immunologiae et therapiae experimentalis 58, 107-119, 2010 | 489 | 2010 |
| Combinatorial strategies for the induction of immunogenic cell death L Bezu, LC Gomes-da-Silva, H Dewitte, K Breckpot, J Fucikova, R Spisek, ... Frontiers in immunology 6, 187, 2015 | 432 | 2015 |
| Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ... Frontiers in immunology 6, 169354, 2015 | 390 | 2015 |
| New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation S Vandevyver, L Dejager, J Tuckermann, C Libert Endocrinology 154 (3), 993-1007, 2013 | 338 | 2013 |
| Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages K Movahedi, S Schoonooghe, D Laoui, I Houbracken, W Waelput, ... Cancer research 72 (16), 4165-4177, 2012 | 318 | 2012 |
| PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity M Gato-Cañas, M Zuazo, H Arasanz, M Ibañez-Vea, L Lorenzo, ... Cell reports 20 (8), 1818-1829, 2017 | 286 | 2017 |
| CD83 expression on dendritic cells and T cells: correlation with effective immune responses C Aerts‐Toegaert, C Heirman, S Tuyaerts, J Corthals, JL Aerts, A Bonehill, ... European journal of immunology 37 (3), 686-695, 2007 | 282 | 2007 |
| PD1 signal transduction pathways in T cells H Arasanz, M Gato-Cañas, M Zuazo, M Ibañez-Vea, K Breckpot, ... Oncotarget 8 (31), 51936, 2017 | 276 | 2017 |
| Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules A Bonehill, C Heirman, S Tuyaerts, A Michiels, K Breckpot, F Brasseur, ... The Journal of Immunology 172 (11), 6649-6657, 2004 | 253 | 2004 |
| Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy S Van Lint, C Goyvaerts, S Maenhout, L Goethals, A Disy, D Benteyn, ... Cancer research 72 (7), 1661-1671, 2012 | 228 | 2012 |
| Current approaches in dendritic cell generation and future implications for cancer immunotherapy S Tuyaerts, JL Aerts, J Corthals, B Neyns, C Heirman, K Breckpot, ... Cancer Immunology, Immunotherapy 56, 1513-1537, 2007 | 225 | 2007 |
| Lentivirally transduced dendritic cells as a tool for cancer immunotherapy K Breckpot, M Dullaers, A Bonehill, S Van Meirvenne, C Heirman, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003 | 213 | 2003 |
| Role of non-classical MHC class I molecules in cancer immunosuppression G Kochan, D Escors, K Breckpot, D Guerrero-Setas Oncoimmunology 2 (11), e26491, 2013 | 178 | 2013 |
| mRNA-based dendritic cell vaccines D Benteyn, C Heirman, A Bonehill, K Thielemans, K Breckpot Expert review of vaccines 14 (2), 161-176, 2015 | 170 | 2015 |
| Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics K Breckpot, JL Aerts, K Thielemans Gene therapy 14 (11), 847-862, 2007 | 165 | 2007 |
| HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7 K Breckpot, D Escors, F Arce, L Lopes, K Karwacz, S Van Lint, M Keyaerts, ... Journal of virology 84 (11), 5627-5636, 2010 | 162 | 2010 |
| Turn back the TIMe: targeting tumor infiltrating myeloid cells to revert cancer progression RM Awad, Y De Vlaeminck, J Maebe, C Goyvaerts, K Breckpot Frontiers in immunology 9, 408722, 2018 | 153 | 2018 |
| Generation of large numbers of dendritic cells in a closed system using Cell Factories™ S Tuyaerts, SM Noppe, J Corthals, K Breckpot, C Heirman, C De Greef, ... Journal of immunological methods 264 (1-2), 135-151, 2002 | 132 | 2002 |
| The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy H Dewitte, S Van Lint, C Heirman, K Thielemans, SC De Smedt, ... Journal of Controlled Release 194, 28-36, 2014 | 131 | 2014 |
